Boreddy SR, Nair R, Pandey PK, Kuriakose A, et al. BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFbeta Signaling to Durably Suppress Tumor Growth. Cancer Res 2023;83:1883-1904.
PMID: 37074042